Interview with Prof. Dr. Jeffrey Drebin, President of the 2024 President Elect of the American Surgical Association.
作者信息
Mimori Koshi, Fujii Tsutomu, Sho Masayuki, Endo Itaru, Shirabe Ken, Kitagawa Yuko
机构信息
Department of Surgery Kyushu University Beppu Hospital Beppu Japan.
Department of Surgery and Science, Faculty of Medicine, Academic Assembly University of Toyama Toyama Japan.
出版信息
Ann Gastroenterol Surg. 2024 Nov 22;9(1):24-31. doi: 10.1002/ags3.12882. eCollection 2025 Jan.
Abstract
摘要
相似文献
1
Interview with Prof. Dr. Jeffrey Drebin, President of the 2024 President Elect of the American Surgical Association.对美国外科协会2024年当选主席杰弗里·德雷宾教授的采访。
Ann Gastroenterol Surg. 2024 Nov 22;9(1):24-31. doi: 10.1002/ags3.12882. eCollection 2025 Jan.
2
3
Dr. Andy Elliott for president-elect of the American Dental Association. Interview by John Thompson.安迪·埃利奥特博士竞选美国牙科协会候任主席。约翰·汤普森采访。
J Tenn Dent Assoc. 2011 Winter;91(1):12-4.
4
An interview with Dr. Burton Press, President-elect of the ADA.对美国牙科协会候任主席伯顿·普雷斯博士的采访。
Alpha Omegan. 1982 Sep;75(3):10-3.
5
Dr. Kerr installed as president; Dr. Houlihan chosen president-elect.克尔博士就任会长；侯利汉博士当选为会长候补。
J Am Dent Assoc. 1979 Dec;99(6):1053-4.
6
Dr Kathy Roth: Our choice for ADA President-Elect. Interview by Mike Maihofer.凯西·罗斯博士：我们对美国牙医学会候任主席的选择。迈克·迈霍费尔采访。
J Mich Dent Assoc. 2005 Mar;87(3):40-4.
7
Interview with Prof. Volker Hömberg, President-Elect of the World Federation for Neurorehabilitation Societies (WFNR).对世界神经康复协会联合会（WFNR）候任主席沃尔克·霍姆贝格教授的采访。
J Med Life. 2022 Oct;15(10):1205-1206. doi: 10.25122/jml-2022-1029.
8
An interview with the President-Elect, Dr. Nelson P. Daly.对当选总统尼尔森·P·戴利博士的采访。
LDA J. 2014 Spring;73(1):6-8.
9
10
Dr. George Bletsas: ninth district candidate for 2001 ADA president-elect. Interview by Michael G. Maihofer.乔治·布莱察斯博士：2001年美国牙科协会候任主席第九选区候选人。迈克尔·G·迈霍费尔采访。
J Mich Dent Assoc. 2001 Mar;83(3):26-30.
本文引用的文献
1
Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.新辅助FOLFIRINOX方案与直接手术治疗可切除胰头癌的比较（NORPACT-1）：一项多中心、随机、2期试验
Lancet Gastroenterol Hepatol. 2024 Mar;9(3):205-217. doi: 10.1016/S2468-1253(23)00405-3. Epub 2024 Jan 15.
2
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial.胰腺和结直肠癌中靶向淋巴结的、mKRAS 特异性两亲体疫苗：AMP-LIFY-201 试验的 1 期研究。
Nat Med. 2024 Feb;30(2):531-542. doi: 10.1038/s41591-023-02760-3. Epub 2024 Jan 9.
3
Efficacy and safety of neoadjuvant nab-paclitaxel plus gemcitabine therapy in patients with borderline resectable pancreatic cancer: A multicenter single-arm phase II study (NAC-GA trial).新辅助白蛋白结合型紫杉醇联合吉西他滨治疗临界可切除胰腺癌患者的疗效和安全性：一项多中心单臂II期研究（NAC-GA试验）
Ann Gastroenterol Surg. 2023 Jul 8;7(6):997-1008. doi: 10.1002/ags3.12712. eCollection 2023 Nov.
4
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer.个体化 RNA 新抗原疫苗可刺激胰腺癌中的 T 细胞。
Nature. 2023 Jun;618(7963):144-150. doi: 10.1038/s41586-023-06063-y. Epub 2023 May 10.
5
Alterations in Somatic Driver Genes Are Associated with Response to Neoadjuvant FOLFIRINOX in Patients with Localized Pancreatic Ductal Adenocarcinoma.局部胰腺导管腺癌患者中，体细胞驱动基因的改变与新辅助 FOLFIRINOX 治疗的反应相关。
J Am Coll Surg. 2022 Aug 1;235(2):342-349. doi: 10.1097/XCS.0000000000000212. Epub 2022 Apr 5.
6
Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study.老年胰腺癌患者新辅助治疗的结果：对比、观察队列研究。
Br J Surg. 2021 Aug 19;108(8):976-982. doi: 10.1093/bjs/znab092.
7
Neoadjuvant or Adjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer: Which Is Preferred?可切除或临界可切除胰腺癌的新辅助治疗或辅助治疗：哪种更优？
J Clin Oncol. 2020 Jun 1;38(16):1757-1759. doi: 10.1200/JCO.19.03318. Epub 2020 Mar 2.
8
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial.可切除及临界可切除胰腺癌的术前放化疗与直接手术对比：荷兰随机III期PREOPANC试验结果
J Clin Oncol. 2020 Jun 1;38(16):1763-1773. doi: 10.1200/JCO.19.02274. Epub 2020 Feb 27.
9
Ablative radiation therapy for locally advanced pancreatic cancer: techniques and results.局部进展期胰腺癌的消融性放疗：技术与结果。
Radiat Oncol. 2019 Jun 6;14(1):95. doi: 10.1186/s13014-019-1309-x.
10
Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer: A Phase 2 Randomized Clinical Trial.吉西他滨和白蛋白紫杉醇联合或不联合羟氯喹治疗晚期胰腺癌患者的效果：一项 2 期随机临床试验。
JAMA Oncol. 2019 Jul 1;5(7):993-998. doi: 10.1001/jamaoncol.2019.0684.
Zotero 插件